These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38223920)

  • 1. Molecular monitoring of treatment efficacy in human visceral leishmaniasis.
    Roy S; Moulik S; Chaudhuri SJ; Ghosh MK; Goswami RP; Saha B; Chatterjee M
    Trans R Soc Trop Med Hyg; 2024 May; 118(5):343-345. PubMed ID: 38223920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the Efficacy and Safety of Liposomal Amphotericin B and Miltefosine in Combination for Treatment of Post Kala-Azar Dermal Leishmaniasis.
    Ramesh V; Dixit KK; Sharma N; Singh R; Salotra P
    J Infect Dis; 2020 Feb; 221(4):608-617. PubMed ID: 31854451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of Parasite Kinetics in Indian Post-Kala-azar Dermal Leishmaniasis.
    Moulik S; Chaudhuri SJ; Sardar B; Ghosh M; Saha B; Das NK; Chatterjee M
    Clin Infect Dis; 2018 Jan; 66(3):404-410. PubMed ID: 29020350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of parasite kinetics with antileishmanial drugs using real-time quantitative PCR in Indian visceral leishmaniasis.
    Sudarshan M; Weirather JL; Wilson ME; Sundar S
    J Antimicrob Chemother; 2011 Aug; 66(8):1751-5. PubMed ID: 21609983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal amphotericin B is more effective in polymorphic lesions of post kala-azar dermal leishmaniasis.
    Moulik S; Sengupta R; Ghosh MK; Das NK; Saha B; Chatterjee M
    Indian J Dermatol Venereol Leprol; 2022; 88(2):201-206. PubMed ID: 33969651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania blood parasite dynamics during and after treatment of visceral leishmaniasis in Eastern Africa: A pharmacokinetic-pharmacodynamic model.
    Verrest L; Monnerat S; Musa AM; Mbui J; Khalil EAG; Olobo J; Wasunna M; Chu WY; Huitema ADR; Schallig HDFH; Alves F; Dorlo TPC
    PLoS Negl Trop Dis; 2024 Apr; 18(4):e0012078. PubMed ID: 38640118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemophagocytic lymphohistiocytosis in imported pediatric visceral leishmaniasis in a nonendemic area.
    Bode SF; Bogdan C; Beutel K; Behnisch W; Greiner J; Henning S; Jorch N; Jankofsky M; Jakob M; Schmid I; Veelken N; Vraetz T; Janka G; Ehl S; Lehmberg K
    J Pediatr; 2014 Jul; 165(1):147-153.e1. PubMed ID: 24797953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring the Long-Term Effectiveness of Miltefosine in Indian Post-Kala-Azar Dermal Leishmaniasis.
    Roy S; Moulik S; Roy M; Ghosh MK; Chaudhuri SJ; Pandey DK; Jain S; Dagne DA; Chatterjee M
    Am J Trop Med Hyg; 2024 Apr; 110(4):656-662. PubMed ID: 38442428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post Kala-Azar dermal leishmaniasis following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India.
    Burza S; Sinha PK; Mahajan R; Sanz MG; Lima MA; Mitra G; Verma N; Das P
    PLoS Negl Trop Dis; 2014; 8(1):e2611. PubMed ID: 24392171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of visceral leishmaniasis in Sri Lanka: a newly established health threat.
    Siriwardana HVYD; Karunanayake P; Goonerathne L; Karunaweera ND
    Pathog Glob Health; 2017 Sep; 111(6):317-326. PubMed ID: 28820339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting Leishmania donovani strain.
    Rai K; Cuypers B; Bhattarai NR; Uranw S; Berg M; Ostyn B; Dujardin JC; Rijal S; Vanaerschot M
    mBio; 2013 Oct; 4(5):e00611-13. PubMed ID: 24105765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parasite load estimation by qPCR differentiates between asymptomatic and symptomatic infection in Indian visceral leishmaniasis.
    Sudarshan M; Sundar S
    Diagn Microbiol Infect Dis; 2014 Sep; 80(1):40-2. PubMed ID: 25023070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Recombinase Polymerase Amplification assay for monitoring parasite load in patients with kala-azar and post kala-azar dermal leishmaniasis.
    Roy M; Ceruti A; Kobialka RM; Roy S; Sarkar D; Wahed AAE; Chatterjee M
    PLoS Negl Trop Dis; 2023 Apr; 17(4):e0011231. PubMed ID: 37075066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral leishmaniasis in a lung transplant recipient: usefulness of highly sensitive real-time polymerase chain reaction for preemptive diagnosis.
    Opota O; Balmpouzis Z; Berutto C; Kaiser-Guignard J; Greub G; Aubert JD; Prod'hom G; Manuel O; Jaton K
    Transpl Infect Dis; 2016 Oct; 18(5):801-804. PubMed ID: 27495987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis.
    Bhandari V; Kulshrestha A; Deep DK; Stark O; Prajapati VK; Ramesh V; Sundar S; Schonian G; Dujardin JC; Salotra P
    PLoS Negl Trop Dis; 2012; 6(5):e1657. PubMed ID: 22629478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia.
    Diro E; Blesson S; Edwards T; Ritmeijer K; Fikre H; Admassu H; Kibret A; Ellis SJ; Bardonneau C; Zijlstra EE; Soipei P; Mutinda B; Omollo R; Kimutai R; Omwalo G; Wasunna M; Tadesse F; Alves F; Strub-Wourgaft N; Hailu A; Alexander N; Alvar J
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0006988. PubMed ID: 30653490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laryngeal leishmaniasis: case report of a rare infection.
    Teemul TA; Giles-Lima M; Williams J; Lester SE
    Head Neck; 2013 Sep; 35(9):E277-9. PubMed ID: 22972594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological monitoring of paediatric visceral leishmaniasis By IFA and ELISA methods.
    Şakru N; Töz SÖ; Korkmaz M; Özbel Y
    Turkiye Parazitol Derg; 2011; 35(3):125-8. PubMed ID: 22203498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-Kala-Azar Dermal Leishmaniasis Without Previous History of Visceral Leishmaniasis.
    Hasnain G; Shomik MS; Ghosh P; Rashid MO; Hossain S; Hamano S; Mondal D
    Am J Trop Med Hyg; 2016 Dec; 95(6):1383-1385. PubMed ID: 27672208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time PCR assay for detection and quantification of Leishmania (Viannia) organisms in skin and mucosal lesions: exploratory study of parasite load and clinical parameters.
    Jara M; Adaui V; Valencia BM; Martinez D; Alba M; Castrillon C; Cruz M; Cruz I; Van der Auwera G; Llanos-Cuentas A; Dujardin JC; Arevalo J
    J Clin Microbiol; 2013 Jun; 51(6):1826-33. PubMed ID: 23554201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.